![Konstantinos Kosmatopoulos](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Konstantinos Kosmatopoulos
Amministratore Delegato presso VAXON Biotech SA
Profilo
Konstantinos Kosmatopoulos is the founder and currently serves as the Chief Executive Officer & Director at VAXON Biotech SA, a company he founded in 2004.
He previously worked as a Research Director at Institut National de la Santé & de la Recherche Médicale and as a Principal at Institut Gustave Roussy EURL.
Dr. Kosmatopoulos obtained his undergraduate and doctorate degrees from Aristotle University of Thessaloniki and Université de Paris XI Paris Sud, respectively.
Posizioni attive di Konstantinos Kosmatopoulos
Società | Posizione | Inizio |
---|---|---|
VAXON Biotech SA
![]() VAXON Biotech SA Pharmaceuticals: MajorHealth Technology VAXON Biotech SA develops therapeutic vaccines for the treatment of cancers. It offers treatment for lung, gastric, prostate, breast, renal, liver, and colorectal cancers, using its proprietary technology of optimized cryptic peptides. The firm also provides research and development services. The company was founded by Konstantinos Kosmatopoulos in 2004 and is headquartered in Paris, France. | Amministratore Delegato | 01/01/2004 |
Precedenti posizioni note di Konstantinos Kosmatopoulos
Società | Posizione | Fine |
---|---|---|
Institut Gustave Roussy EURL
![]() Institut Gustave Roussy EURL Miscellaneous Commercial ServicesCommercial Services Institut Gustave Roussy EURL is a cancer research and treatment center that places innovation at the heart of its services. The private company is based in Chevilly-Larue, France, and has subsidiaries in France. The center has strong partnerships at national and international levels to provide high-value care to all its patients. Patients' rights are protected and guaranteed to ensure their autonomy, respect for their individual liberties, and dignity within the hospital. | Corporate Officer/Principal | - |
Institut National de la Santé & de la Recherche Médicale
![]() Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Konstantinos Kosmatopoulos
Aristotle University of Thessaloniki | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 4 |
---|---|
VAXON Biotech SA
![]() VAXON Biotech SA Pharmaceuticals: MajorHealth Technology VAXON Biotech SA develops therapeutic vaccines for the treatment of cancers. It offers treatment for lung, gastric, prostate, breast, renal, liver, and colorectal cancers, using its proprietary technology of optimized cryptic peptides. The firm also provides research and development services. The company was founded by Konstantinos Kosmatopoulos in 2004 and is headquartered in Paris, France. | Health Technology |
Université de Paris XI Paris Sud | Consumer Services |
Institut National de la Santé & de la Recherche Médicale
![]() Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Commercial Services |
Institut Gustave Roussy EURL
![]() Institut Gustave Roussy EURL Miscellaneous Commercial ServicesCommercial Services Institut Gustave Roussy EURL is a cancer research and treatment center that places innovation at the heart of its services. The private company is based in Chevilly-Larue, France, and has subsidiaries in France. The center has strong partnerships at national and international levels to provide high-value care to all its patients. Patients' rights are protected and guaranteed to ensure their autonomy, respect for their individual liberties, and dignity within the hospital. | Commercial Services |
- Borsa valori
- Insiders
- Konstantinos Kosmatopoulos